NorthWest Biotherapeutics Inc (NWBO)

[polska]

DNDN did not let their trials play out to establish a long survival tail benefit and the naysayers focused on the modest improvement in median survival. The attacks on the DNDN stock are comparable to the manipulation of NWBO. The approval of Provenge obviously caught some entities in a large naked short positions and they did everything necessary to take DNDN back down (with the help of the stumbling DNDN management). Perhaps some of the same players are behind the attacks on NWBO?